Friday, May 24, 2013

Podcast: Beth Halford on the plight (and joys) of being a postdoc

Beth Halford and I sat down to have a quick chat about the life of postdocs, based on her really interesting article in this week's C&EN. It was really fun and the edited recording is below:



Timepoints:

0:00 - 2:00: What's been the background of postdocs?
4:30: The happiness of postdocs
6:30: The postdocs that Beth knew
7:00: Crowdfunding a postdoc (CJ grossly underestimates the cost of a FTE)
8:55: PIs and their postdocs
9:50: Should we pay postdocs more? Beth on Paula Stephan
11:00: $16/hour
12:00: Why do a postdoc?
13:30: The finances of postdocs
15:11: Jessica Breen's cogent comments on delaying life milestones?
17:15: Are postdocs really broader?
19:45: The postdoc arms race
22:17: The longest postdoc you've heard of
23:55: When will the arms race be over?
27:55: What should postdocs do about getting a job?

Thanks to Beth for a great conversation!

Thursday, May 23, 2013

Interview: Mary Beth Mulcahy, CSB investigator

Mary Beth Mulcahy is a Ph.D. chemist and a Chemical Safety Board investigator. She was kind enough to offer me some of her time for an e-mail interview. What follows is an e-mail interview; it has been formatted for the blog and is basically unedited.

Can you tell us a little about your background? 

Dr. Mulcahy: Public school education mixed with a paper route, fast food jobs, and Science Olympiad in high school eventually led me to a major in chemistry at a private liberal arts school called Colorado College in Colorado Springs. By a chance meeting with someone at a party the last month of my senior year in college, I landed a high school teaching job in a small mountain town that eventually lead me to a teaching job in New York City. After three years of teaching, I went back to tackle a PhD in physical chemistry at the University of Colorado in Boulder. The National Science Foundation provided the funding for a post-doc in Bariloche, Argentina at the Centro Atómico. After returning from my post-doc, I taught high school again for one year before working for a biotech company and then ultimately the CSB.

How did you end up working at CSB? 

Dr. Mulcahy: When I started graduate school at 25 I suppose I thought I would get a PhD and be a professor, but somewhere along the way I realized that I did not want that career path. When I came back from my post-doc, I took a job at the high school where my husband was teaching because they really needed someone and I thought it would be fun to teach again. If anyone out there ever forgets why they got into science in the first place, I highly recommend he or she get a part-time job teaching high school science and then spend the entire year doing interesting demos and experiments with the students that get at real-life problems. (I say part-time because teaching is an incredibly time-consuming job and I do not think one could get the full enjoyment from it if he or she had a full teaching load.)

While I thoroughly enjoy teaching and definitely see myself doing it again toward the end of my career, I really wanted to see what I could do with a PhD. I took full advantage of ACS's help for the unemployed chemist and attended a national meeting for free (I think ACS still lets unemployed members attend for free) where I listened to a seminar on how to use the web to find a job (this was an amazing seminar put on by someone from Google I believe), participated in a kind of speed-dating type round table session to get exposure to other career options for a chemist, and communicated with a mentor that the ACS connected me to. Then, I started searching for a job using two methods I repeatedly read would not work--I cold called companies and answered Craigslist job posts. I was able to secure three interviews and two jobs using the methods.

I originally saw a CSB job posted on Craigslist and the description intrigued me. The CSB at that point was clearly looking for a chemical engineer who had worked in a chemical plant or refinery, but the CSB was also looking for interns. Never one to pass up an interesting opportunity, I applied for the internship and ultimately obtained the position almost a full year after I originally applied. So that year I believe the CSB had two 22 year-old interns, one 23 year-old intern, and me who was over thirty and had a PhD. Still amuses me to think that is how I got here.

What do you do from day-to-day at CSB? 

Dr. Mulcahy: To explain what I do day-to-day I need to give a little background on what the Chemical Safety Board does. At the CSB we conduct root cause investigations of chemical accidents. At first glance, you might think a root cause would be technical in nature such as identifying the corrosion mechanism that lead to the failure of a pipe or storage vessel. More often than not, the corrosion mechanism (or hazard) is well known and awareness of its existence was not enough to preclude the accident. As a result, we focus on finding a correctable failure in the underlying management system that enabled the conditions to develop which ultimately lead to the accident.

During the life cycle of an investigation, my day-to-day activities change depending on whether I am in the office or deployed. Typically we deploy to an accident scene within the first days after the incident has occurred. The early focus is securing the scene to preserve evidence and interviewing eye witnesses.

Once this initial phase passes, we enter into a reiterative process both in the field and the office of reviewing documents, testing equipment/samples, and conducting interviews to understand the equipment/system that failed and the management system it operated in. In the office I spend a lot of time reading through company provided documents, researching technical issues, and coordinating testing. It is much like a down day in the lab when you spend time doing literature searches, plot your data, and maybe contact other scientists about papers they have written. What I like most about office work is every case presents new learning opportunities in science, law/policy, and safety.

Our goal is not to simply fix a single company, but to effect change in an industry so advocacy work is important. This means attending meetings with regulators and  professional organizations that generate best practice guidance to begin a dialogue about the recommendations that the CSB is considering submitting and presenting initial (or final) findings to help promote the safety change we are advocating. After a report is released, outreach remains important and so I give many presentations around the country as well.

What I don’t do on a daily basis is any bench chemistry because the CSB does not have its own laboratories, though I use my chemistry skills often to interface with contractors and in all of the analysis that I do.

What level of experience or expertise do typical CSB investigators have, before they join? 

Dr. Mulcahy: This is extremely varied. The CSB investigators range from just out of college to over 25 years industry experience. In addition to myself, the CSB recruits employees with backgrounds in engineering(chemical, safety, mechanical), human factors, environmental science/policy, occupational health/safety, public policy, chemical accident investigations, and lawyers. Safety and PSM experience at refineries and/or chemical process facilities would help you succeed at the CSB.

If someone wanted a job like yours at CSB, what would you recommend that they do? 

Dr. Mulcahy: If you are still in college I would suggest you pursue internships in the oil and chemical industries or at the CSB (we have internships).  Also enroll in classes that will give you exposure to safety issues in the oil and chemical industries.  If you are working in the industry volunteer for safety investigations and for assignments that take you out of your comfort zone such as researching codes/regulations or writing sections of the final safety investigation report.  Finally, speaking of writing - it is so important for our jobs –no matter where you are in your career take technical writing classes and learn how to communicate technical information to non technical audiences.

What do you think is most misunderstood about the TTU/Preston Brown case? I confess that I am tempted by the 'it was a guy being dumb' answer, and I understand that, safety culture-wise, that's insufficient.  

Dr. Mulcahy: That accidents happen because of “rogue” researchers and if you take the researcher out of the system, an accident will not happen. Look at the TTU report and take the student out of the equation, all the other system deficiencies still existed. Perhaps the exact accident wouldn’t occur if the researcher were removed, but the deficiencies leave the door open for a different accident.

If you were to talk to a group of young graduate students about academic lab safety, what 3 things would you recommend? 

Dr. Mulcahy: I have a full-time job investigating worst-case scenarios and major accidents, they are not as rare as you think.

Learn how to conduct a hazard analysis. This will absolutely require you to talk to more senior researchers since it is difficult to identify hazards in a process you are unfamiliar with.

There is no perfect safety barrier, which means any barrier could fail at any time. Look for inherently safer methods to accomplish your goals, but if you can’t be sure to design your experiments with multiple safety barriers to minimize the risk to you.

If you were to talk to a group of experienced laboratory chemists about chemical lab safety (or chemical plant safety, for that matter), what 3 things would you recommend?

Dr. Mulcahy: Really, I would say the same things I did above.

There is a great quote on safety culture that says it is “…how the organization behaves when no one is watching.”  (American Institute of Chemical Engineers (AICHE), Safety Culture: What is at Stake?,  on 6/16/2011.) I would tell them this quote and then ask if they put on their goggles (even if they were normal eyeglasses) every time they walked into their laboratories.

What gets measured gets paid attention to, and so I would recommend they find ways to actively measure safety in their laboratories. (I just published something about this in a joint paper with other authors for the Journal of Chemical Health and Safety that might be useful to a reader wanted more of an explanation )

CJ here again. Thanks to Dr. Mulcahy for a great interview!

Job posting: Visiting Assistant Professor, Greensboro, NC

From the inbox: 
Guilford College invites applications for a full-time, one-year position in the Chemistry department beginning August 15, 2013. Teaching responsibilities include one organic chemistry lecture and three organic and general chemistry laboratories. A Ph.D. in Organic Chemistry is preferred, but ABD applicants are encouraged to apply. Applicants should electronically submit a cover letter, current vita, statement of teaching philosophy and areas of scholarly interest and research activities, transcripts, and contact information for three references at http://guilford.peopleadmin.com. (Posting Number: F00015)
Best wishes! Click here for details.  

Job posting: Visiting Assistant Professor, Lebanon, TN

From the inbox, a visiting assistant professor position:
Cumberland University seeks applications for a visiting assistant professor position in chemistry as a sabbatical replacement.  Demonstrated excellence in teaching, scholarship, and university service are highly desirable.  Duties include teaching chemistry courses from general chemistry to upper division courses at the undergraduate level, university committee work, recruiting, and assessment. 
Click here for details.  

Daily Pump Trap: 5/23/13 edition

Good morning! Between May 21 and May 22, there were 9 new positions posted on the C&EN Jobs website. Of these, 8 (89%) were from Kelly Scientific Resources.

It's a cure all, too:Reynolds American is looking for a B.S. chemist/flavor scientist (emphasis mine):
R.J. Reynolds Tobacco Company is seeking an experienced Flavor Scientist with knowledge in flavor chemistry to support the development of tobacco products consistent with RJRT's Growth, Innovation and Harm Reduction Platforms. The Flavor Scientist is responsible for developing new and innovative taste profiles to support project initiatives and for the sensory assessment of tobacco products. 
Requirements: BA/BS technical degree required in chemistry, biology or food science with three or more years relevant work experience or MS in related science field with relevant work experience. 
This position requires smoking to assess the sensory characteristics of cigarettes; therefore, is open to current smokers only.
That's pretty awesome. (Q: "How did you get your job?" A: "Well, I'm a pack-a-day smoker.")

*Yes, I recognize the song is about chewing tobacco, but I just love the song so. 

A broader look: Monster, Careerbuilder, Indeed and USAjobs.gov show (respectively) 247, 13, 2779 and 14 positions for the search term "chemist." LinkedIn shows 110 positions for the job title "chemist", with 9 for "research chemist", 15 for "analytical chemist" and 2 for "organic chemist."

Wednesday, May 22, 2013

10 ul microsyringes

A list of small, useful things (links):
Readers, did I miss anything? 

The most interesting paragraph I read today

My sincere apologies with the relatively quiet posting recently. I do indeed have a Process Wednesday post in the works, but I found this to be such an interesting framing of the issue by Alyssa Rosenberg, commenting on Sheryl Sandberg's Lean In and her approach to looking at childcare costs that I had to post it:
Similarly, Sandberg suggests a different way to look at the cost of child care. Rather than considering nannying or preschool costs as a dilemma, something that wipes out a woman’s earnings, or that’s discretionary spending to allow a woman to continue doing something that she likes, Sandberg once again reframes the question, acknowledging that “Child care is a huge expense, and it’s frustrating to work hard just to break even. But professional women need to measure the cost of child care against their future salary rather than their current salary…Wisely, Anna and other women have started to think of paying for child care as a way of investing in their families’ future.” 
Sandberg makes a very interesting point and one that I hadn't considered. When I calculate child care for our family budget, I usually do the math against our income (numerator = child care, denominator = wages). I had not taken into account that, over time, the wages term goes up...

[One should point out that for those, like Ms. Sandberg, who have/desire offices in the C-suite, the beginning years of one's career probably play much more of a role in future income than those of us to aspire to more mundane titles like "group leader" or "senior principal fellow."] 

Tuesday, May 21, 2013

Not a surprise for some reason

Imagine reading an article on private spaceflight in New York magazine and coming across this interesting tidbit (emphasis mine):
Virgin Galactic’s CEO is a 39-year-old American named George Whitesides, who I met one evening after ISPCS. The son of a legendary chemist, he is himself a nonscientist who decided to devote his life to space one night in Tunisia, while studying women’s rights in the Islamic world on a Fulbright scholarship, when he found himself walking on the shore of the Mediterranean beneath an impossibly starry sky. He’s worked for Virgin for three years—recruited by Branson from NASA, where he served as the administrator’s chief of staff—but has been a customer for almost a decade: He and his wife, self-described “space geeks,” were among the first to set down a combined $400,000 for Virgin’s then-rather-speculative flights. It was meant, even at the time, to be a delayed honeymoon. 
George Whitesides (the senior?) is known to all as a character -- somehow not a surprise that his son would be radically different as well.

[The article is worth a read -- sounds like private spaceflight will be interesting and off-beat. I am, for the most part, a techno-optimist; I think that trends have always been towards popularizing technology that was initially only accessible to the very wealthy. All of that to say that I think that more people will be able to experience spaceflight than we ever imagined.] 

Daily Pump Trap: 5/21/13 edition

Good morning! Between May 16 and May 20, there were 51 new positions posted to the C&EN Jobs website. Of these, 2 (4%) were academically connected and 44 (86%) were from Kelly Scientific Resources.

Athens, GA: Noramco (a Johnson & Johnson subsidiary) is looking for a B.S./M.S./Ph.D. senior analytical chemist; 6+ years experience desired.

Aurora, Illinois: Aurora Specialty Textiles Group is looking for a M.S. chemist to be a senior coatings chemist. 10+ years experience desired.

Classic Kelly: "Bustling Lab Technician." (Crockett, ?) 

Ivory Filter Flask: 5/21/13 edition

Good morning! Between May 14 and May 20, there were 4 academic positions posted on the C&EN Jobs website. The numbers:

Total number of ads: 4
- Postdocs: 0
- Tenure-track faculty:  1
- Temporary faculty: 0
- Lecturer positions:  2
- Staff positions:  1
- US/non-US: 3/1

Abu Dhabi: New York University Abu Dhabi is looking for an assistant instructor for general and organic chemistry:
New York University has established a campus in Abu Dhabi, United Arab Emirates, and invites applications for several Assistant Instructor positions. We encourage applicants with experience in teaching, preferably at the undergraduate level, and in planning and conducting laboratory experiments in organic, physical and analytical chemistry. An M.S., B.S. or PhD with teaching and research experience in chemistry is preferred.
So what you're really saying is: we'll take anyone. (For those intrigued by this Abu Dhabi position, here's a recent write-up of the campus by New York magazine.)

Jupiter, FL: Scripps Florida is looking for a Ph.D. NMR core facility manager; why do they prefer local residents?

Memphis, TN: The University of Tennessee Health Science Center is looking for an assistant/associate/full professor of pharmaceutics:
The successful candidate is expected to have a strong research program in the areas of pharmaceutics, physical pharmacy, drug delivery, gene therapy, nanotechnology, nanomedicine, regenerative medicine, bio-imaging, biosensors, biomedical engineering, or other related discipline with focus on drug discovery and development. 
Casting a broad net, I see.

Monday, May 20, 2013

C&EN: Is it wise to do multiple postdocs?



My short answer: no. 

3 true things in that Beth Halford article, and one awesome industrial inconsistency

3 true things and one awesome inconsistency that I was glad to see in Beth Halford's article on the current state of the chemistry postdoctoral fellow in this week's C&EN:

It's the job market: From Kelly O. Sullivan, a very, very good point:
“The challenge that postdocs are facing is probably the same that everyone is facing: a weak job market,” says Kelly O. Sullivan, who manages the Linus Pauling Distinguished Postdoctoral Fellowships at Pacific Northwest National Laboratory and is the current president of Sigma Xi, the Scientific Research Society.
I wonder if the senior industrial executives quoted in the article would be willing to admit that they were (or at least "the industry" or "the economy" was) part of the problem.

Hey, these salaries aren't so great: It's great to see a look at how inflation affects postdoc salaries:
Salaries reflect another disturbing development: Postdoc chemists seem to be making less money than they used to. According to the ACS survey, in 2005 the median salary for postdocs was $36,000. In 2012 it was $40,000. 
Although those numbers suggest that salaries are edging upward, they’re not when adjusted for inflation, says Gareth S. Edwards, senior research associate with the Department of Research & Member Insights at ACS. “Unfortunately, real dollar value—what that salary will buy you—is slowly decreasing, meaning that postdocs are earning less each year,” he says. From 2005 to 2012, salaries increased 11.1%, while the Consumer Price Index rose 16.1%.
I'll put my cards on the table and say that I am not one of the people who really buys into the "inflation is killing us!!!" theory of the post-recession economy and the Federal Reserve's activities. That said, inflation is still there, and it is interesting to note that like senior citizens, postdocs and other folks who rely on a stipend (that's not tied to merit, or subject to regular raises) are basically on a fixed income. Huh.

Life milestone opportunity costs: I found Jessica Breen's comments about her twin very interesting and true:
Because of the transient nature of the position, many postdocs end up putting off major life decisions, such as getting married and having children, until after they’ve finished their studies. “I have a twin sister, who I think is a good example of a normal person my age who is exactly like me but who isn’t a postdoc,” says Jessica Breen, a second-year postdoc at the University of Leeds, in England. “My sister is married. She’s got a mortgage and a house. She’s just had her first baby. I haven’t even thought about buying a house. I can’t even think about getting married because I don’t have money to do so.”
I wonder what would happen if people said, "if you do this postdoc, you're going to delay getting married or buying a house for another couple of years?" (For the most part, the answer would be, "beats starving, or continuing to be a graduate student.")

Check out this massive disagreement between Dow's Banholzer, DuPont and Vertex: Remember the Banholzer Award, where Dow's William Banholzer said this?:
But you'll notice that a history of postdocing is not among the characteristics that appear in Banholzer's description. "I don't think I need to hire postdocs," he told PCAST. A Ph.D. earned under an excellent professor is sufficient education, he says, because Dow provides newly hired scientists its own training for the work that they will be doing. "They sort of get their postdoc on the job," he notes. 
Here's what other industrial executives think:
Industrial employers’ opinions are more variable, but they still give postdocs an edge. “It is a slight positive but by no means necessary for our jobs,” says Gary S. Calabrese, senior vice president at Corning. “If there is a particular technical need we have and someone has the right skills, it does not matter if it came through their Ph.D. or a postdoc. Having said this, of course those with postdoctoral experience are by definition broader and have a greater chance of being a technical match for us.” 
Pat N. Confalone, vice president of DuPont Crop Protection, tells C&EN that although a postdoc isn’t a requirement to get a job at DuPont, it is a definite plus. “All things being equal, someone who has a postdoc is going to be more attractive to industry than someone without a postdoc,” he says. 
“The majority of applicants that we see have postdoctoral experience,” adds Mark Namchuk, senior vice president of research for North America with Vertex Pharmaceuticals. “A postdoc is not essential, but it is becoming the norm. Aside from the additional experience, it often provides diversification of a scientist’s skill set.”
First, I think "those with postdoctoral experience are by definition broader" is a potential stretch. What is the evidence of this? I think that graduate students and their doctoral and postdoctoral advisers are well-served to make sure that's true.

I think the true test is this: are chemists with postdocs paid more in industry or hired faster than those who do not? I think I have made the case before that there is a potential opportunity cost in salary to taking a postdoc; as I said then, if it helps you get you hired, then it's worth it.

Readers, what do you think? 

NAS study on academic chemical safety to begin

Also from this week's C&EN, a report by Jeff Johnson that the National Academy of Sciences is going to look into academic chemical safety:
Safety in academic and other nonindustrial chemical research laboratories will be the focus of a yearlong investigation by a National Academy of Sciences committee, which held its first meeting last week in Washington, D.C. The study will consider how safe lab practices can be promoted in academic and government labs, explained H. Holden Thorp, committee chairman, chemistry professor, and chancellor of the University of North Carolina, Chapel Hill. 
The examination sprang from numerous chemistry-related lab accidents, particularly ones at the University of California, Los Angeles, in December 2008, and Texas Tech University in January 2010. Since the Texas Tech incident, 65 accidents* (see update) have occurred at academic and government chemical research labs, according to Mary Beth Mulcahy, a Chemical Safety & Hazard Investigation Board (CSB) investigator who spoke at the meeting. Those accidents injured 136 and killed two.
Several speakers stressed anecdotal evidence indicating that industrial labs are safer than nonindustry labs. But little hard data emerged to demonstrate or explain the proposed difference. The committee will investigate if such differences are real, and if so, whether industry safety measures can be applied to nonindustry labs.
There have been two deaths in academic and government chemical research labs since TTU in January 2010. One of them is likely Michelle Dufault, the student who died in a Yale machine shop. The other? I am not sure. Anyone know which incident Dr. Mulcahy might be referring to?* (see update)

I'm looking forward to a statistical look by NAS on the differences between academic and industrial labs; I'm tired of the anecdotal evidence.

UPDATE: Jyllian Kemsley writes in the comments:
CJ, we erred in how we framed that statistic. It should be "65 accidents have occurred at academic, government, and industrial chemical research labs." We're working on correcting the story. 
Regarding the two deaths, Mulcahy doesn't count Dufault because the incident occurred in a machine shop rather than a chemistry lab. The two deaths are: 
- Adrian Martin, Membrane Technology & Research, gas cylinder explosion
- Unidentified Battelle contractor, Aberdeen Proving Ground, lab explosion and fire 
There's one more lab death that Mulcahy doesn't count, because it was microbiology rather than chemistry: Richard Din, San Francisco Veterans Affairs Medical Center, bacterial infection contracted from the lab.
Thanks to Jyllian for the fast response.

BASF to expand its worldwide research spending

From this week's C&EN, an article on BASF by Alex Scott that might be good news for U.S. chemical-industry jobseekers over the next few years:
The Americas and Asia will each get 25% of BASF’s research budget and scientists by 2020 under a plan being advanced by Andreas Kreimeyer, BASF’s board member responsible for research. The company now conducts most of its research in Europe, but to get closer to its customers and work with the world’s best scientists, it must venture outside the Continent, according to Kreimeyer. [snip]
...BASF already increased its R&D spending outside Europe by 3% in 2012 with the opening of seven new labs and the extension of existing labs in Asia-Pacific and the U.S. For example, the firm launched its Innovation Campus Asia Pacific in Shanghai for up to 450 scientists. It’s also rolling out a research center for battery materials in Amagasaki, Japan, opening a mining R&D center in Perth, Australia, and has plans to introduce an R&D center in India. 
BASF has “substantially strengthened” its R&D efforts in the Americas, Kreimeyer said. Notable U.S. projects include a new lab in Wyandotte, Mich., for developing thermoplastic polyurethanes in cooperation with customers in the automotive, building, construction, and sports industries across North America. 
Also in the U.S., BASF, in association with Harvard University, Massachusetts Institute of Technology, and the University of Massachusetts, recently inaugurated the American Center for Research on Advanced Materials. Over the next five years, the partners aim to develop microstructures and nanostructured polymers with new properties and come up with bioinspired materials.
Well, that's certainly good news for Michigan, it seems. The academic/industrial collaboration model seems to be alive and well these days, no? It will be very interesting to see how it works out for the industry over the next 5 to 10 years. 

Friday, May 17, 2013

Hey, that's not the right data!

Some of you may have seen this James Hicks article in The Scientist, where he shows a graph that seems to correlate high notices of retractions with low NIH grant success rates. Interesting idea, right?

Unfortunately, Nature reporter Richard Van Noorden (the collector of some of the data used in the graph) notes that Professor Hicks did not use the most relevant data for his retractions (i.e. US retractions, funded by the NIH) for his graph. When you do, the correlation is not nearly so clear.

I agree with Richard that the hypothesis is sound (i.e. as it gets more difficult to get funded, the incentive to cheat goes up), but it remains unproven. 

Man, I want to go to China someday to give a talk

From international political economy professor Daniel Drezner, a comment on being paid honoraria for speaking in China:
1) From a personal perspective, as the occasional visitor to China, I can confirm the wads of cash thing -- but it's a bit more complicated than Barboza suggests. First of all, for U.S. academics at least, the payment isn't in renminbi, but in U.S. dollars. Renminbi is sometimes dispensed for things like per diem reimbursements, but not for honoraria. After all, officially, the RMB is still not convertible to dollars outside of the country, so it wouldn't be very nice to get paid in a currency that is technically useless outside the People's Republic. 
There are two other qualifiers here. First, at least with respect to academic honoraria, it's not just China that pays in cash -- so does Japan, for example. Second, speaking as an academic who's received the occasional honorarium, it's friggin' awesome. At some point, someone takes you aside and gives you an envelope stuffed with bills. I know it's impolite to say, but every time it happens, I feel like I'm an earner in Tony Soprano's crew. It's soooooo much more satisfying than getting a check (as is the norm in the U.S.) or receiving a bank transfer three months later than it should be and only after haranguing someone a few times (as is the norm in Europe). 
Having just worked in the United States, I haven't had the pleasure of being paid in cash. (I've been paid in work experience and donuts -- why do you ask?) Whenever I go to the ATM to pull out a couple hundred bucks when we go on vacation, I always feel a little weird.

Readers, what's the best way you've been paid?

Thursday, May 16, 2013

Awesome, enraging articles to read

This day has been busy (as you might be able to tell), but a few things to talk about:
  • This C&EN article by Beth Halford on the current state of the postdoc and the problem of chemists taking multiple postdocs is definitely worth a read and worth further comment. I love the quotes from senior industrial folks; it'll be great to see how their opinions match with how their companies have been hiring. 
  • Derek Lowe has a couple of great comments today:
    • The first, about an Atlantic article that talks about the problems with getting Western pharmaceutical companies to address neglected/tropical diseases. Derek has some problems with the article, naturally. I do too, especially with the thought that the solution to the problem is getting the global (i.e. non-developed world's) pharmaceutical manufacturing capacity to solve the problem. 
    • Coincidentally, the second great comment is about Fortune magazine's fantastic exposé of the quality issues and outright fraud that was happening at Ranbaxy's plants in India for about a decade. For example, they were using submitting bioequivalence data to the FDA using drug manufactured by brand-name companies or competitors. After reading that article, I am not sure how Ranbaxy has managed to stay in business. 
All three of these articles deserve your attention (and mine!)

It's a simple question: do you care about your people, or your career?

Nick Palmisciano is a former infantry officer in the U.S. Army. At the start of an interesting set of comments about being a new Army infantry officer (engagingly titled "Don't Be A Douche"), an interesting comment on caring about your people:
2.) Your guys are more important than your career.  
This ties in nicely with my last point, but it is worthy of its own bullet.  You’re all going to be civilians someday, no matter how much you love the military or how long you serve.  Years from now, the fact that you made Colonel or Sergeant Major won't erase the fact that you threw some unsuspecting subordinate under the bus to avoid punishment, and it certainly won't remove a stupid decision you made based on pressure from above that got someone killed or injured.  Every leader I've ever respected has been willing to stand in the Gates of Fire when it mattered.  If you're not willing to do this for your people, be honest with yourself and quit.  Join corporate America – you'll just annoy people, not get them killed, and you'll make more money.  Everyone wins.
I'm reminded of (former Marine commandant) Al Gray's comment to The Basic School in Tom Ricks' great book Making the Corps:
What bothers him most about today's military, he goes on to say, is careerism. It has eroded the other services  he warns, and is creeping into the Corps. The only thing you should worry about, he tells the assembled second lieutenants, is taking care of your people. In fact, he recommends adding one new little box to the officer evaluation reports: It would say, Does this officer care more about his career than about his troops? A "yes" mark would terminate that officer's career. 
Obviously, the evaluation criteria for officers in the military and managers in the chemical and pharmaceutical industries are very different. The military expects 'leadership' (a vague term, to be sure) out of its officers and senior non-commissioned officers as a primary responsibility; that's not necessarily the case for the business world.

However, I believe that direct reports can sense when supervisors and managers see them as valued members of a team (not, I note, just by referring to them as "a team") and not human data collection devices that will provide information/products/processes that will lead to greater corporate glory.*

I'm not naive enough to think that there isn't a mutual benefit aspect to this, of course. A good way to move up in the world is "make your boss look good." (Making your boss look bad, of course, is a good way to move down as well.) Direct reports are very, very good at sensing when that "mutual benefit" is out of balance, and they're even better at sensing when managers are actively taking credit for results and decisions that they did not make.

I agree with General Gray -- larger organizations should take note of the potential careerism of their employees and incorporate it into their evaluations of managers. I am, of course, hopelessly naive.

*This is probably where industry's long-time model for scientific administration may be failing. It is usually the case that the person at the top is some combination of "the smartest scientist" and "the most senior person" and "the person most likely to make good decisions." Somehow, that got translated into "to be a people manager/supervisor, you probably need a Ph.D." Academics don't teach leadership/mentorship skills to their graduate students, and I am not sure that they should. 

Daily Pump Trap: 5/16/13 edition

Good morning! Between May 14 and May 15, there were 15 jobs posted on the C&EN Jobs website. Of these, 2 (13%) were academically connected and 9 (60%) were from Kelly Scientific Resources.

Zeroes!: Vertex (Cambridge, MA) continues its run of hiring with a B.S./M.S./Ph.D. chemical development position. 0-3+ years experience for Ph.D.s, 5+ for M.S., 8+ for B.S. positions.

San Jose, CA: Energy Storage Stealth is a startup, doing something very interesting that I can't quite tell what it is...:
We are a new start-up, located in San Jose, California, that is working on a fundamental disruption in the field of energy storage. The company seeks to change the paradigm in energy storage by developing a completely new class of electrical energy storage device. If successful, the technology could revolutionize the industry. We are backed by top VC firms. 
Gotta love the buzzwords. Description of the position:
The candidate will own the formulation development process and scale up production of inks, slurries, and chemical process solutions.  The candidate is required to identify conditions and variables for formulation stability and quality, and undertake continuous process improvement using statistical DOE.  This person will develop a qualification process and a characterization infrastructure for formulations and must be familiar with SPC environment.  The candidate is expected to identify, specify, purchase, and implement process and equipment for scale up.  The ideal candidate is self-motivated, team oriented, can work independently and in teams, and is seeking an atmosphere conducive to learning and growth.
What's weird about it is that the pay is listed as $160-$180. What's that about? Oh, and this too: "Additional Salary Information: start-up so equity play"

A broader look: Monster, Careerbuilder, Indeed and USAjobs.gov show (respectively) 241, 730, 2751 and 14 positions for the search term "chemist." LinkedIn shows 99 positions for the job title "chemist", with 4 for "organic chemist", 14 for "analytical chemist" and 10 for "research chemist."

Bonus via LinkedIn: Nintendo of America is looking for a QC chemist, I think.